Immunotherapy: Targeting MDSCs with LXR agonists
- PMID: 29384146
- DOI: 10.1038/nrclinonc.2018.17
Immunotherapy: Targeting MDSCs with LXR agonists
Comment on
-
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.Cell. 2018 Feb 8;172(4):825-840.e18. doi: 10.1016/j.cell.2017.12.026. Epub 2018 Jan 11. Cell. 2018. PMID: 29336888 Free PMC article.
References
-
- Cell. 2018 Feb 8;172(4):825-840.e18 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources